Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stuart

Showing results (441-450 of 469) with videos related to

Pageof 47
Sort By:
Leukemia & Lymphoma|November 26, 2019
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemiaJonathan E Kolitz, Stephen A Strickland, Jorge E Cortes, et al.
Nature Communications|September 13, 2023
Single-cell isotope tracing reveals functional guilds of bacteria associated with the diatom Phaeodactylum tricornutumXavier Mayali, Ty J Samo, Jeff A Kimbrel, et al.
British Journal of Haematology|November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAnjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 13, 2001
Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantationJ R Jonsson, C Hong, D M Purdie, et al.
Haematologica|November 9, 2014
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemiaJeffrey E Lancet, Gail J Roboz, Larry D Cripe, et al.
American Journal of Physiology. Renal Physiology|May 26, 2005
Zebrafish slc4a2/ae2 anion exchanger: cDNA cloning, mapping, functional characterization, and localizationBoris E Shmukler, Christine E Kurschat, Gabriele E Ackermann, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 5, 2026
International Society for Diseases of the Esophagus consensus on the diagnosis and treatment of anastomotic leak after esophagectomySanne K Stuart, Jobbe M G Lemmens, Grard A P Nieuwenhuijzen, et al.
Blood|April 18, 2013
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemiaStephen H Petersdorf, Kenneth J Kopecky, Marilyn Slovak, et al.
Current Treatment Options in Oncology|January 15, 2003
Oral cancer treatmentTerry A Day, Betsy K Davis, M Boyd Gillespie, et al.
Nature Genetics|February 6, 2007
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genomeNathaniel D Heintzman, Rhona K Stuart, Gary Hon, et al.
Pageof 47

Showing results (441-450 of 469) with videos related to

Sort By:
Pageof 47
Leukemia & Lymphoma|November 26, 2019
Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemiaJonathan E Kolitz, Stephen A Strickland, Jorge E Cortes, et al.
Nature Communications|September 13, 2023
Single-cell isotope tracing reveals functional guilds of bacteria associated with the diatom Phaeodactylum tricornutumXavier Mayali, Ty J Samo, Jeff A Kimbrel, et al.
British Journal of Haematology|November 30, 2010
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAnjali S Advani, Holly M Gundacker, Olga Sala-Torra, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 13, 2001
Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantationJ R Jonsson, C Hong, D M Purdie, et al.
Haematologica|November 9, 2014
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemiaJeffrey E Lancet, Gail J Roboz, Larry D Cripe, et al.
American Journal of Physiology. Renal Physiology|May 26, 2005
Zebrafish slc4a2/ae2 anion exchanger: cDNA cloning, mapping, functional characterization, and localizationBoris E Shmukler, Christine E Kurschat, Gabriele E Ackermann, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 5, 2026
International Society for Diseases of the Esophagus consensus on the diagnosis and treatment of anastomotic leak after esophagectomySanne K Stuart, Jobbe M G Lemmens, Grard A P Nieuwenhuijzen, et al.
Blood|April 18, 2013
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemiaStephen H Petersdorf, Kenneth J Kopecky, Marilyn Slovak, et al.
Current Treatment Options in Oncology|January 15, 2003
Oral cancer treatmentTerry A Day, Betsy K Davis, M Boyd Gillespie, et al.
Nature Genetics|February 6, 2007
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genomeNathaniel D Heintzman, Rhona K Stuart, Gary Hon, et al.
Pageof 47